Indefinite Delivery Contract SPE2DX15D9237

The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to military health facilities worldwide. The $499,999,999 IDC, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of the Department of Defense.

Task orders issued against this IDC include deliveries of contraceptive devices such as Kyleena and Nexplanon, as well as other pharmaceutical items like Surgilube lubricant, vaccines, and specialty medications. The contract has no set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories. The contract's period of performance runs through December 2025, with the place of performance primarily based in DMS Pharmaceutical Group's facility located in Park Ridge, Illinois.